Kezar Life Sciences Inc.(KZR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KZR Kezar Life Sciences Inc.

Post-Market Trading 06-12 16:42:52 EDT

0.7099

+0.0014

+0.20%

盘后0.7099

+0.00000.00%

16:20 EDT

High0.7540	Low0.7005	Vol478.08K
Open0.7247	D1 Closing0.7085	Amplitude7.55%
Mkt Cap51.68M	Tradable Cap37.26M	Total Shares72.80M
T/O348.02K	T/O Rate0.91%	Tradable Shares52.48M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"KZR","market":"US","secType":"STK","nameCN":"Kezar Life Sciences Inc.","latestPrice":0.7099,"timestamp":1718222400000,"preClose":0.7085,"halted":0,"volume":478080,"hourTrading":{"tag":"盘后","latestPrice":0.7099,"preClose":0.7099,"latestTime":"16:20 EDT","volume":5003,"amount":3551.6297,"timestamp":1718223600557},"delay":0,"floatShares":52481480,"shares":72801359,"eps":-1.394341,"marketStatus":"Post-Market Trading","change":0.0014,"latestTime":"06-12 16:42:52 EDT","open":0.7247,"high":0.754,"low":0.7005,"amount":348016.813131,"amplitude":0.075512,"askPrice":0.7514,"askSize":100,"bidPrice":0.6833,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.394341,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1718236800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":0.7085,"preHourTrading":{"tag":"盘前","latestPrice":0.7027,"preClose":0.7085,"latestTime":"09:22 EDT","volume":33,"amount":23.2065009,"timestamp":1718198555548},"postHourTrading":{"tag":"盘后","latestPrice":0.7099,"preClose":0.7099,"latestTime":"16:20 EDT","volume":5003,"amount":3551.6297,"timestamp":1718223600557},"volumeRatio":0.943831,"impliedVol":1.3302,"impliedVolPercentile":0.6706},"requestUrl":"/m/hq/s/KZR/","defaultTab":"news","newsList":[{"id":"2441701235","title":"Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2441701235","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2441701235?lang=en_us&edition=fundamental","pubTime":"2024-06-08 05:59","pubTimestamp":1717797540,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., June 07, 2024----Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that the Compensation Committee of the company’s Board of Directors granted one employee a nonqualified stock option to purchase 80,000 shares of its common stock with an exercise price of $0.71 per share, which is equal to the closing price of Kezar’s common stock on June 3, 2024, the grant date of the award. The stock option was granted as an inducement award material to the individual entering into employment with Kezar, in accordance with Nasdaq Listing Rule 5635.The stock option will vest over a four-year period, with 25% of the option vesting on the first anniversary of the employee’s start date, and 1/48th of the total shares vesting monthly thereafter, subject to continued employment on each vesting date. The option is subject to the terms and con","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/j2.EwmCp2V_lwwtKnX_3WQ--~B/aD0zNjA7dz0xMTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/0fcef8465266f33fe98da48042062b10","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/j2.EwmCp2V_lwwtKnX_3WQ--~B/aD0zNjA7dz0xMTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/0fcef8465266f33fe98da48042062b10"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kezar-announces-inducement-grant-under-215900589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2210149790.SGD","QID","QLD","BK4588","BK4139","NQmain","LU2210150020.SGD","BK4585","BK4112","KZR","NDAQ","QQQ","TQQQ","MNQmain","PSQ","LU2095319765.USD","SQQQ",".IXIC"],"gpt_icon":0},{"id":"2441268412","title":"BRIEF-Kezar Notified By Nasdaq In Letter Dated May 31, Co's Application To Transfer To Nasdaq Capital Market Was Approved","url":"https://stock-news.laohu8.com/highlight/detail?id=2441268412","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2441268412?lang=en_us&edition=fundamental","pubTime":"2024-06-05 04:52","pubTimestamp":1717534370,"startTime":"0","endTime":"0","summary":"June 4  - Kezar Life Sciences Inc   :   * KEZAR LIFE SCIENCES INC -NOTIFIED BY NASDAQ IN LETTER DATED MAY 31, CO’S APPLICATION TO TRANSFER TO NASDAQ CAPITAL MARKET WAS APPROVED   * KEZAR LIFE SCIENCES-ELIGIBLE FOR ADDITIONAL 180 CALENDAR DAY PERIOD, OR UNTIL NOV 25 TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENTSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","PSQ","QLD","BK4112","LU2210150020.SGD","NDAQ","BK4139","BK4585","QQQ",".IXIC","KZR","SQQQ","NQmain","TQQQ","LU2210149790.SGD","BK4588","QID","MNQmain"],"gpt_icon":0},{"id":"2439688884","title":"Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2439688884","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2439688884?lang=en_us&edition=fundamental","pubTime":"2024-05-30 04:01","pubTimestamp":1717012860,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., May 29, 2024----Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that Chris Kirk, Co-founder and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 12:30 pm ET in New York, NY.Investor and Media Contact:Gitanjali JainVice President, Investor Relations and External AffairsKezar Life Sciences, Inc.gjain@kezarbio.com","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/n_G8alAHVc3Ph2JPuCFACg--~B/aD0zNjA7dz0xMTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/446777392f354cc106185240c97bfb19","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/n_G8alAHVc3Ph2JPuCFACg--~B/aD0zNjA7dz0xMTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/446777392f354cc106185240c97bfb19"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kezar-life-sciences-participate-jefferies-200100456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HCSG","KZR","BK4139","BK4137"],"gpt_icon":0},{"id":"2437495267","title":"Kalamazoo Resources Seeks ASX Share Quotation","url":"https://stock-news.laohu8.com/highlight/detail?id=2437495267","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2437495267?lang=en_us&edition=fundamental","pubTime":"2024-05-21 16:28","pubTimestamp":1716280080,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. (AU:KZR) has released an update. Kalamazoo Resources Ltd. is applying for the quotation of over 5 million of its ordinary ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-seeks-asx-share-quotation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-seeks-asx-share-quotation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2435575777","title":"Kalamazoo Resources Issues New Employee Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2435575777","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435575777?lang=en_us&edition=fundamental","pubTime":"2024-05-15 08:57","pubTimestamp":1715734625,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. (AU:KZR) has released an update. Kalamazoo Resources Ltd. has announced the issuance of 1,950,000 unquoted options set to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-new-employee-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-issues-new-employee-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2434343198","title":"Buy Rating Affirmed for Kezar Life Sciences Amid Promising Clinical Trials and Strong Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2434343198","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434343198?lang=en_us&edition=fundamental","pubTime":"2024-05-10 18:45","pubTimestamp":1715337958,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences (KZR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju fro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-kezar-life-sciences-amid-promising-clinical-trials-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-kezar-life-sciences-amid-promising-clinical-trials-and-strong-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2434257460","title":"Kezar Life Sciences GAAP EPS of -$0.30","url":"https://stock-news.laohu8.com/highlight/detail?id=2434257460","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434257460?lang=en_us&edition=fundamental","pubTime":"2024-05-10 05:29","pubTimestamp":1715290159,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences press release  (NASDAQ:KZR): Q1  GAAP EPS of -$0.30.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4104260-kezar-life-sciences-gaap-eps-of--030","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2434040038","title":"Kezar Life Sciences Q1 EPS $(0.30) Beats $(0.33) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2434040038","media":"Benzinga","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434040038?lang=en_us&edition=fundamental","pubTime":"2024-05-10 04:40","pubTimestamp":1715287207,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 3.23 percent increase over losses of $(0.31) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38745793/kezar-life-sciences-q1-eps-0-30-beats-0-33-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR"],"gpt_icon":0},{"id":"2434981042","title":"BRIEF-Kezar Life Sciences Q1 Net Income USD -21.658 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2434981042","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434981042?lang=en_us&edition=fundamental","pubTime":"2024-05-10 04:01","pubTimestamp":1715284905,"startTime":"0","endTime":"0","summary":"May 09 (Reuters) - Kezar Life Sciences Q1 operating expenses USD 23.711 million. * Q1 operating income USD -23.711 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","USD","KZR"],"gpt_icon":0},{"id":"2434408647","title":"Kalamazoo Resources Highlights Investment Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2434408647","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434408647?lang=en_us&edition=fundamental","pubTime":"2024-05-09 08:08","pubTimestamp":1715213317,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. (AU:KZR) has released an update. Kalamazoo Resources Ltd. has released an investment presentation outlining its mineral pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-highlights-investment-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-highlights-investment-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2433272410","title":"Kezar Life Sciences Inc    expected to post a loss of 33 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2433272410","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2433272410?lang=en_us&edition=fundamental","pubTime":"2024-05-07 19:23","pubTimestamp":1715081017,"startTime":"0","endTime":"0","summary":"* Kezar Life Sciences Inc     is expected to show a rise in quarterly revenue when it reports  results on May 9 (estimated) for the period ending March 31 2024   * The South San Francisco California-b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR"],"gpt_icon":0},{"id":"2433238139","title":"Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2433238139","media":"Business Wire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2433238139?lang=en_us&edition=fundamental","pubTime":"2024-05-07 04:05","pubTimestamp":1715025900,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., May 06, 2024----Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that the Compensation Committee of the company’s Board of Directors granted two employees nonqualified stock options to purchase 164,000 shares of its common stock with an exercise price of $0.84 per share, which is equal to the closing price of Kezar’s common stock on May 1, 2024, the grant date of the awards. The stock options were granted as an inducement award material to the individuals entering into employment with Kezar, in accordance with Nasdaq Listing Rule 5635.The stock options will vest over a four-year period, with 25% of each option vesting on the first anniversary of the employee’s start date, and 1/48th of the total shares vesting monthly thereafter, subject to continued employment on each vesting date. The options are subject to the terms ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/FpkhB05SzYzeIzcpS5Z1Sg--~B/aD0zNjA7dz0xMTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e0580bcd90cabe72f29284f8977464f8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/FpkhB05SzYzeIzcpS5Z1Sg--~B/aD0zNjA7dz0xMTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e0580bcd90cabe72f29284f8977464f8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kezar-announces-inducement-grants-under-200500068.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","NDAQ","NQmain","QLD","BK4585","TQQQ","MNQmain","BK4588",".IXIC","BK4112","LU2095319765.USD","LU2210149790.SGD","KZR","SQQQ","PSQ","QQQ","LU2210150020.SGD","BK4139"],"gpt_icon":0},{"id":"2430123462","title":"Kalamazoo Resources Advances Lithium and Gold Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2430123462","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2430123462?lang=en_us&edition=fundamental","pubTime":"2024-04-26 14:27","pubTimestamp":1714112850,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. (AU:KZR) has released an update. Kalamazoo Resources Ltd. has successfully launched Kali Metals on the ASX, with the IPO r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-advances-lithium-and-gold-projects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-advances-lithium-and-gold-projects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2430212301","title":"Kalamazoo Resources Navigates Cash Flow Dynamics","url":"https://stock-news.laohu8.com/highlight/detail?id=2430212301","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2430212301?lang=en_us&edition=fundamental","pubTime":"2024-04-26 14:17","pubTimestamp":1714112256,"startTime":"0","endTime":"0","summary":"Kalamazoo Resources Ltd. (AU:KZR) has released an update. Kalamazoo Resources Limited reported a quarterly cash outflow from operating activities o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-navigates-cash-flow-dynamics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalamazoo-resources-navigates-cash-flow-dynamics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2422266009","title":"From Pennies to Fortunes: 3 Stocks Set to Make Millionaires","url":"https://stock-news.laohu8.com/highlight/detail?id=2422266009","media":"InvestorPlace","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2422266009?lang=en_us&edition=fundamental","pubTime":"2024-03-28 04:30","pubTimestamp":1711571400,"startTime":"0","endTime":"0","summary":"Galiano Gold : Its record throughput and high recovery rates signify operational excellence.Aurora : The consistent commercial progress highlights market acceptance of autonomous trucking solutions.All leverage collaborations with other industry players to expand their market reach and accelerate product development.But the trip still needs to go on. Explorers see autonomous driving solutions emerging in the future as they focus on Aurora Innovation . The technology of the third one paves the path for the transportation revolution and redefines possibilities beyond the intergalactic roads of trade.Furthermore, Galiano Gold produced 31,947 ounces of gold in Q4. As seen by the134,077 ouncesproduced in 2023, this amount adds to the general trend of rising output. Finally, this year’s production surpassed the updated production projection’s 120,000–130,000-ounce upper limit. Overall, such a steady output increase shows the business’s operational expertise and ability to reach and exceed go","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://investorplace.com/2024/03/from-pennies-to-fortunes-3-stocks-set-to-make-millionaires/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investorplace_stock_picks","symbols":["BK4124","BK4557","BK4229","ACB","BK4137","BK4195","KZR","GAU","BK4139","BK4023","BK4007","AUR","BK4017","CTTAF","AGM"],"gpt_icon":0},{"id":"2422056519","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kezar Life Sciences (KZR), Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Cue Health (HLTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2422056519","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2422056519?lang=en_us&edition=fundamental","pubTime":"2024-03-25 20:20","pubTimestamp":1711369253,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kezar Life Sciences (KZR – Research Report), Fisher & Paykel Heal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-kezar-life-sciences-kzr-fisher-paykel-healthcare-corporation-limited-otherfspkf-and-cue-health-hlth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-kezar-life-sciences-kzr-fisher-paykel-healthcare-corporation-limited-otherfspkf-and-cue-health-hlth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HLTH","BK4082","KZR","BK4137","HCSG","BK4139"],"gpt_icon":0},{"id":"2419194511","title":"Diamonds in the Dust: 3 Penny Stocks Set to Soar 500% by 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2419194511","media":"InvestorPlace","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419194511?lang=en_us&edition=fundamental","pubTime":"2024-03-16 18:56","pubTimestamp":1710586560,"startTime":"0","endTime":"0","summary":"Learn how these penny stocks may yield a 5X return with their lead in application software and biotechnology.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://investorplace.com/2024/03/diamonds-in-the-dust-3-penny-stocks-set-to-soar-500-by-2026/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investorplace_stock_picks","symbols":["LU1571399168.USD","BK4137",".IXIC","BK4557","BK4149","BK4585","SQQQ","AUR","BK4588","MNQmain","NQmain","EGHT","BK4139","PSQ","QQQ","TQQQ","KZR","ACB","QID","BK4023","QLD","BK4007","PCAR","BK4550"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kezarlifesciences.com","stockEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0831},{"period":"3month","weight":-0.2214},{"period":"6month","weight":-0.1674},{"period":"1year","weight":-0.7108},{"period":"ytd","weight":-0.2522}],"compareEarnings":[{"period":"1week","weight":0.0162},{"period":"1month","weight":0.0309},{"period":"3month","weight":0.0407},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.2378},{"period":"ytd","weight":0.1297}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor that is in Phase 2b clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; Phase 1b clinical trials in systemic lupus erythematosus; and completed Phase 2a clinical trials in lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.101182},{"month":2,"riseRate":0.833333,"avgChangeRate":0.110013},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.094959},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.079081},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.18188},{"month":6,"riseRate":0.5,"avgChangeRate":0.064869},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.081807},{"month":8,"riseRate":0.666667,"avgChangeRate":0.008901},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003986},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.065252},{"month":11,"riseRate":0.833333,"avgChangeRate":0.203618},{"month":12,"riseRate":0.5,"avgChangeRate":0.060618}],"exchange":"NASDAQ","name":"Kezar Life Sciences Inc.","nameEN":"Kezar Life Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.0","shortVersion":"4.24.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kezar Life Sciences Inc.(KZR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kezar Life Sciences Inc.(KZR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kezar Life Sciences Inc.,KZR,Kezar Life Sciences Inc.股票,Kezar Life Sciences Inc.股票老虎,Kezar Life Sciences Inc.股票老虎国际,Kezar Life Sciences Inc.行情,Kezar Life Sciences Inc.股票行情,Kezar Life Sciences Inc.股价,Kezar Life Sciences Inc.股市,Kezar Life Sciences Inc.股票价格,Kezar Life Sciences Inc.股票交易,Kezar Life Sciences Inc.股票购买,Kezar Life Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kezar Life Sciences Inc.(KZR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kezar Life Sciences Inc.(KZR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction